Title | Type | SJR | H index | Total Docs. (2002) | Total Docs. (3years) | Total Refs. (2002) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2002) | %Female (2002) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
77 | Journal of B.U.ON. | journal | 0.106 Q4 | 37 | 72 | 247 | 1642 | 9 | 229 | 0.04 | 22.81 | 31.68 | |
76 | Journal of Tumor Marker Oncology | journal | 0.108 Q4 | 9 | 0 | 58 | 0 | 5 | 58 | 0.08 | 0.00 | 0.00 | |
75 | Clinical and Translational Oncology | journal | 0.115 Q4 | 61 | 94 | 124 | 2270 | 17 | 94 | 0.14 | 24.15 | 36.62 | |
74 | Electronic Journal of Oncology | journal | 0.123 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
73 | Familial Cancer | journal | 0.146 Q4 | 67 | 0 | 32 | 0 | 12 | 29 | 0.38 | 0.00 | 0.00 | |
72 | International Journal of Pediatric Hematology/Oncology | journal | 0.152 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
71 | Breast Disease | journal | 0.154 Q4 | 36 | 32 | 52 | 1481 | 11 | 50 | 0.21 | 46.28 | 29.55 | |
70 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.158 Q4 | 50 | 6 | 206 | 1312 | 65 | 206 | 0.23 | 218.67 | 18.99 | |
69 | Cancer Research, Therapy and Control | journal | 0.178 Q4 | 13 | 10 | 174 | 175 | 35 | 169 | 0.27 | 17.50 | 26.09 | |
68 | Bulletin du Cancer | journal | 0.180 Q4 | 44 | 178 | 544 | 5343 | 256 | 443 | 0.48 | 30.02 | 31.86 | |
67 | Pathogenesis | journal | 0.184 Q4 | 8 | 0 | 13 | 0 | 5 | 13 | 0.14 | 0.00 | 0.00 | |
66 | Prostate Journal | journal | 0.191 Q4 | 7 | 0 | 76 | 0 | 14 | 71 | 0.23 | 0.00 | 0.00 | |
65 | Gann Monographs on Cancer Research | book series | 0.196 Q4 | 10 | 0 | 63 | 0 | 25 | 60 | 0.24 | 0.00 | 0.00 | |
64 | Oncology Research and Treatment | journal | 0.200 Q4 | 55 | 115 | 365 | 2500 | 192 | 316 | 0.56 | 21.74 | 16.12 | |
63 | Journal of Brachytherapy International | journal | 0.205 Q4 | 12 | 0 | 84 | 0 | 22 | 83 | 0.26 | 0.00 | 0.00 | |
62 | Prostate Cancer and Prostatic Diseases | journal | 0.215 Q4 | 78 | 62 | 257 | 1450 | 109 | 232 | 0.29 | 23.39 | 13.61 | |
61 | Tumori | journal | 0.216 Q3 | 59 | 219 | 638 | 3833 | 300 | 609 | 0.33 | 17.50 | 34.62 | |
60 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.268 Q3 | 56 | 54 | 182 | 1413 | 127 | 174 | 0.72 | 26.17 | 51.48 | |
59 | Progress in Experimental Tumor Research | book series | 0.269 Q3 | 20 | 0 | 25 | 0 | 15 | 25 | 0.00 | 0.00 | 0.00 | |
58 | Cancer Cell International | journal | 0.271 Q3 | 80 | 16 | 3 | 403 | 5 | 3 | 1.67 | 25.19 | 30.61 | |
57 | Human Cell | journal | 0.288 Q3 | 44 | 23 | 86 | 471 | 85 | 84 | 0.97 | 20.48 | 15.69 | |
56 | Cancer Treatment and Research | journal | 0.316 Q3 | 65 | 59 | 136 | 4825 | 101 | 136 | 0.70 | 81.78 | 36.30 | |
55 | Japanese Journal of Clinical Oncology | journal | 0.317 Q3 | 95 | 127 | 434 | 2080 | 313 | 384 | 0.67 | 16.38 | 13.66 | |
54 | Journal of Experimental and Clinical Cancer Research | journal | 0.343 Q3 | 120 | 116 | 266 | 2860 | 278 | 262 | 0.89 | 24.66 | 30.06 | |
53 | Tumor Targeting | journal | 0.384 Q3 | 10 | 0 | 32 | 0 | 35 | 31 | 0.00 | 0.00 | 0.00 | |
52 | In Vivo | journal | 0.439 | 72 | 86 | 284 | 3603 | 343 | 282 | 1.23 | 41.90 | 33.13 | |
51 | Hematological Oncology | journal | 0.478 Q3 | 54 | 15 | 41 | 996 | 54 | 41 | 1.17 | 66.40 | 51.35 | |
50 | Oral Oncology | journal | 0.497 Q3 | 137 | 128 | 520 | 4143 | 606 | 506 | 0.83 | 32.37 | 25.06 | |
49 | Pathology and Oncology Research | journal | 0.510 Q3 | 61 | 47 | 147 | 1326 | 176 | 147 | 1.14 | 28.21 | 38.20 | |
48 | BMC Cancer | journal | 0.522 Q3 | 160 | 37 | 20 | 1200 | 30 | 20 | 1.50 | 32.43 | 29.21 | |
47 | Leukemia and Lymphoma | journal | 0.522 Q3 | 102 | 388 | 914 | 12210 | 1399 | 900 | 1.38 | 31.47 | 29.63 | |
46 | Oncology Reports | journal | 0.529 Q3 | 115 | 239 | 732 | 5423 | 1042 | 732 | 1.29 | 22.69 | 21.23 | |
45 | Breast Cancer Research | journal | 0.545 Q3 | 175 | 78 | 372 | 1834 | 448 | 330 | 1.48 | 23.51 | 49.74 | |
44 | Journal of Oral Pathology and Medicine | journal | 0.587 Q3 | 95 | 97 | 261 | 2778 | 490 | 258 | 1.61 | 28.64 | 24.85 | |
43 | Anticancer Research | journal | 0.626 Q3 | 136 | 658 | 2358 | 19065 | 4117 | 2354 | 1.61 | 28.97 | 27.80 | |
42 | Invasion and Metastasis | journal | 0.640 Q2 | 31 | 0 | 11 | 0 | 22 | 11 | 0.00 | 0.00 | 0.00 | |
41 | Cancer Epidemiology | journal | 0.642 Q2 | 86 | 59 | 201 | 2435 | 333 | 199 | 1.47 | 41.27 | 39.15 | |
40 | Journal of Neuro-Oncology | journal | 0.666 Q2 | 135 | 147 | 455 | 4911 | 838 | 444 | 1.61 | 33.41 | 25.78 | |
39 | Lung Cancer | journal | 0.667 Q2 | 148 | 251 | 458 | 6323 | 1042 | 434 | 2.16 | 25.19 | 21.10 | |
38 | Leukemia Research | journal | 0.687 Q2 | 96 | 172 | 449 | 4860 | 842 | 397 | 1.95 | 28.26 | 32.03 | |
37 | Virus Research | journal | 0.699 Q2 | 144 | 162 | 386 | 6189 | 651 | 383 | 1.54 | 38.20 | 32.86 | |
36 | Journal of Cancer Research and Clinical Oncology, Supplement | journal | 0.711 Q2 | 13 | 0 | 18 | 0 | 49 | 18 | 2.72 | 0.00 | 0.00 | |
35 | Angiogenesis | journal | 0.717 Q2 | 101 | 29 | 69 | 1523 | 94 | 68 | 0.90 | 52.52 | 33.33 | |
34 | Acta Oncologica, Supplement | journal | 0.747 Q2 | 8 | 0 | 12 | 0 | 31 | 12 | 0.00 | 0.00 | 0.00 | |
33 | International Journal of Biological Markers | journal | 0.751 Q2 | 47 | 46 | 140 | 1021 | 263 | 122 | 1.77 | 22.20 | 45.11 | |
32 | Journal of Cancer Research and Clinical Oncology | journal | 0.773 Q2 | 109 | 106 | 316 | 3050 | 726 | 305 | 2.28 | 28.77 | 30.84 | |
31 | Neuro-Oncology | journal | 0.773 Q2 | 163 | 29 | 89 | 1096 | 187 | 85 | 1.92 | 37.79 | 35.33 | |
30 | Cancer Chemotherapy and Pharmacology | journal | 0.846 Q2 | 122 | 142 | 503 | 4357 | 1233 | 499 | 2.36 | 30.68 | 30.89 | |
29 | Cancer Letters | journal | 0.848 Q2 | 216 | 371 | 1117 | 11674 | 2677 | 1114 | 2.50 | 31.47 | 28.69 | |
28 | International Journal of Hyperthermia | journal | 0.871 Q2 | 98 | 49 | 126 | 2002 | 223 | 122 | 1.88 | 40.86 | 22.90 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®